Sector Update: Health Care Stocks Edge Higher in Afternoon Trading

MT NewswiresJun 29 02:07

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target

BenzingaJun 29 01:30

Agenus Analyst Ratings

BenzingaJun 29 01:29

Agenus Shares Rise 12% After Positive Data From Botensilimab/Balstilimab Study

WSJJun 29 01:10

Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients

MT NewswiresJun 29 00:00

Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress

BenzingaJun 28 23:10